IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科
学科主题临床医学
Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B
Li, Min-Ran; Xi, Hong-Li; Wang, Qin-Huan; Hou, Feng-Qin; Huo, Na; Zhang, Xia-Xia; Li, Fang; Xu, Xiao-Yuan
刊名PLOS ONE
2014-06-06
DOI10.1371/journal.pone.0098476
9期:6
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Multidisciplinary Sciences
资助者12th Five-Year Plan ; Beijing Municipal Science and Technology Commission of major projects ; 12th Five-Year Plan ; Beijing Municipal Science and Technology Commission of major projects
研究领域[WOS]Science & Technology - Other Topics
关键词[WOS]CLOSED CIRCULAR DNA ; SURFACE-ANTIGEN ; LAMIVUDINE THERAPY ; ADEFOVIR DIPIVOXIL ; ANTIVIRAL AGENTS ; NATURAL-HISTORY ; ENTECAVIR ; REDUCTION ; VIRUS ; CCCDNA
英文摘要

Background & Aims: About 350-400 million people are infected with hepatitis B virus (HBV) chronically and 1 million people die of hepatitis B virus (HBV)-related liver diseases. Nucleos(t)ide analogues (NAs) have been used for the treatment against HBV. However, few studies have investigated the long-term effects of different nucleos(t)ide analogues on levels of hepatitis B surface antigen (HBsAg) in patients with chronic hepatitis B (CHB). The aims of this study were to measure the magnitude of HBsAg reduction by long-term monotherapy with adefovir dipivoxil (ADV) and entecavir (ETV), to compare HBsAg reduction between the two drugs of different potency and to predict the expected time needed to achieve HBsAg loss.

Methods: We retrospectively evaluated the kinetics of HBsAg in 67 patients with CHB who all exhibited persistent viral suppression. These patients were treated with ADV or ETV for at least 6 years. HBV genotype was determined at baseline. Liver biochemistry, HBV serological markers, serum HBV DNA and HBsAg titers were determined at baseline, half year and yearly from year 1 to 6.

Results: Serum HBsAg titers after treatment with ADV or ETV were significantly lower than the baseline titers (P<0.05). HBsAg reduction rate of patients treated with ETV (0.11 log(10) IU/mL/year) was higher than that treated with ADV (0.10 log(10) IU/mL/year), and the calculated expected time to HBsAg loss for patients treated with ETV (approximate 24.99 years) was shorter than that with ADV (approximate 30.33 years), but there was no statistically significant difference between two groups (P>0.05).

Conclusion: Serum HBsAg titers gradually decreased during long-term treatment with either ADV or ETV. It appears that the potency of ADV on HBsAg reduction is close to that of ETV, as long as patients have achieved persistent viral suppression.

语种英语
所属项目编号2012ZX10002 003-004-003 ; 2013 ZX10002004-001-003 ; D121100003912003
资助者12th Five-Year Plan ; Beijing Municipal Science and Technology Commission of major projects ; 12th Five-Year Plan ; Beijing Municipal Science and Technology Commission of major projects
WOS记录号WOS:000341869000033
Citation statistics
Cited Times:7[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60704
Collection北京大学第一临床医学院_感染疾病科
作者单位Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Li, Min-Ran,Xi, Hong-Li,Wang, Qin-Huan,et al. Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B[J]. PLOS ONE,2014,9(6).
APA Li, Min-Ran.,Xi, Hong-Li.,Wang, Qin-Huan.,Hou, Feng-Qin.,Huo, Na.,...&Xu, Xiao-Yuan.(2014).Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B.PLOS ONE,9(6).
MLA Li, Min-Ran,et al."Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B".PLOS ONE 9.6(2014).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Li, Min-Ran]'s Articles
[Xi, Hong-Li]'s Articles
[Wang, Qin-Huan]'s Articles
百度学术
百度学术Similar articles in
[Li, Min-Ran]'s Articles
[Xi, Hong-Li]'s Articles
[Wang, Qin-Huan]'s Articles
必应学术
必应学术Similar articles in
[Li, Min-Ran]'s Articles
[Xi, Hong-Li]'s Articles
[Wang, Qin-Huan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.